Our Company Strategy & Mission Leadership Our Board Partnering Opportunities Out-Licensing Opportunities Contact Our Pipeline Clinical Trials Disease Information Innovation Engine Akeso Partnership Overview Ivonescimab (SMT112) Overview Therapeutic Areas News Center Media Resources Press Releases Investor Center Investor Center Announcements, Financial Reports & Filings Email Alerts Share Price Data Analyst Coverage Corporate Governance Board of Directors Diversity Matrix Shareholder Meetings Summit Presentations Career Opportunities
In Vitro Pharmacodynamics Of The Novel Antibiotic SMT19969 Against Clostridium Difficile In Vitro Pharmacodynamics Of The Novel Antibiotic SMT19969 Against Clostridium Difficile April 12, 2014 By CKD Digital
In Vitro Pharmacodynamics Of The Novel Antibiotic SMT19969 Against Clostridium Difficile April 12, 2014 By CKD Digital
